⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 15, 2014Circulation Cardiovascular Imaging

T 1 Mapping Detects Pharmacological Retardation of Diffuse Cardiac Fibrosis in Mouse Pressure-Overload Hypertrophy

View Full Paper

Ask AI

Bookmark

Share

Authors

DSDaniel J. StuckeyCardiac Imaging SMSara J. McSweeneyNational Institutes of Health MTMay Zaw ThinInstitute of Cancer Research

Discussion

Loading...

Member takes

Implication

T1 mapping detects losartan-mediated fibrosis suppression in murine TAC; leaves open clinical translation pending human validation.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Stuckey et al. (2014) studied this question.

synapsesocial.com/papers/6a85124cfbd9f4f9f9bdfd55 https://doi.org/10.1161/circimaging.113.000993

Topics

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Evaluation of Diffuse Myocardial Fibrosis in Heart Failure With Cardiac Magnetic Resonance Contrast-Enhanced T1 Mapping2008 · 745 citations
2Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction2012 · 284 citations
3Quantification of Cardiomyocyte Hypertrophy by Cardiac Magnetic Resonance2013 · 127 citations
4Quantification of Diffuse Myocardial Fibrosis and Its Association With Myocardial Dysfunction in Congenital Heart Disease2010 · 265 citations
5Novel MRI method to detect altered left ventricular ejection and filling patterns in rodent models of disease2008 · 46 citations